Categories
Connect with us on LinkedIn
Biotech AI strategy for clinical teams | LinkedIn Live
LinkedIn Live event tile featuring Derk Arts, CEO of Castor, and Solomon Babani, Founder and CEO of Symbiosis...
Early-stage biotech’s AI advantage is a window that closes. Sol Babani and Derk Arts on how to use it.
Sol Babani and Derk Arts on why early-stage biotech must build AI-native operations, not retrofit old ones. Decision...
ICH E6(R3) compliance for biotech studies
See how Castor's unified platform helps biotech sponsors meet ICH E6(R3) oversight, data integrity, and site burden requirements.
ePRO for biotech: capture economic evidence from day one
Castor ePRO helps biotech sponsors capture HEOR-ready evidence from Phase I/II. Audit-proof, 92%+ participant compliance.
